Please login to the form below

Not currently logged in
Email:
Password:

obinutuzumab

This page shows the latest obinutuzumab news and features for those working in and with pharma, biotech and healthcare.

AbbVie, Roche’s Venclyxto combo reduces risk of death in first-line AML

AbbVie, Roche’s Venclyxto combo reduces risk of death in first-line AML

In March, the European Commission approved Venclyxto in combination with Gazyvaro (obinutuzumab) as a chemotherapy-free therapy for previously-untreated chronic lymphocytic leukaemia (CLL).

Latest news

More from news
Approximately 11 fully matching, plus 30 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

How community outreach can help improve diversity in clinical research
To execute a considered community engagement strategy, an involved and collaborative process is needed....
OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward
...
Can eLearning improve patient recruitment and retention?
Some patients will still want to read pages of informed consent forms before joining a clinical trial, or want timely updates on paper rather than a notification on their phone....

Infographics